It is noted that apigenin does not drive the formation of prostate intraepithelial neoplasia and suppresses MYB to indirectly reduce the mobility of cancer cells, to avoid metastasis and cell proliferation for lean PCa. Here, MYB is linked to prostate intraepithelial neoplasia.